We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




European Laboratory Information Systems Market

By Labmedica staff writers
Posted on 23 Nov 2006
Print article
The classic laboratory information system (LIS), designed as a multi-functional system to support hospital laboratory activities with emphasis on work and specimen flow for hospital inpatients and outpatients, has been dominant in clinical laboratories for more than three decades. This has led to 90-95% market penetration levels for LIS software.

According to Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm, the European laboratory information systems market earned revenues of U.S.$153.7 million in 2005 and is estimated to reach U.S.$218.1 million in 2012.

Hospital laboratories are changing rapidly with greater emphasis on point-of-care and outreach testing, working in tandem with other automated systems in the hospital. Across Europe, almost half of the hospitals have a dedicated laboratory system. Vendors have therefore seen this as an opportunity to persuade hospitals of the benefits of an integrated hospital-wide system using the LIS as a selling tool.

"For many hospitals, the changes in LIS are related to a drive to connect together various hospital departments and departmental software,” explained Frost & Sullivan industry analyst Konstantinos Nikolopoulos. "Clinicians want to be able to enter data into electronic records and they want to both import and export data from electronic medical records [EMR] and hospital information systems [HIS] to LIS and vice-versa.”

Past trends have indicated that customers do not switch over to new vendors very easily, either due to financial considerations or simply to avoid the process of implementing new systems. "Market participants will need to show increased visibility in such a competitive environment,” advises Mr. Nikolopoulos. "Attendance and participation in trade shows and other industry-wide events can build company awareness, while the ability to highlight product capabilities and features in test/pilot sites can be an additional step in the same direction.”




Related Links:
Frost & Sullivan
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Histamine ELISA
Histamine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.